| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Pseudomonas aeruginosa |
>0.5 |
>8 |
≤0.06 － >8 |
Levofloxacin (Levaquin, Quixin) |
479 |
| Pseudomonas aeruginosa |
>0.5 |
>16 |
0.12 － >16 |
Levofloxacin (Levaquin, Quixin) |
12 |
| Pseudomonas aeruginosa |
0.5 |
16 |
0.125 － >256 |
Levofloxacin (Levaquin, Quixin) |
497 |
| Pseudomonas aeruginosa |
0.5 |
16 |
0.25 － >64 |
Levofloxacin (Levaquin, Quixin) |
55 |
| Pseudomonas aeruginosa |
>0.78 |
>100 |
0.39 － >100 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Pseudomonas aeruginosa |
>1 |
>8 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
36 |
| Pseudomonas aeruginosa |
>1 |
>8 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
36 |
| Pseudomonas aeruginosa |
>=1 |
≥16 |
≤0.008 － >=16 |
Levofloxacin (Levaquin, Quixin) |
475 |
| Pseudomonas aeruginosa |
1 |
64 |
0.5 － >64 |
Levofloxacin (Levaquin, Quixin) |
225 |
| Pseudomonas aeruginosa |
1.56 |
12.5 |
0.2 － >100 |
Levofloxacin (Levaquin, Quixin) |
40 |
| Pseudomonas aeruginosa |
>2 |
>8 |
≤0.008 － >8 |
Levofloxacin (Levaquin, Quixin) |
42 |
| Pseudomonas aeruginosa |
2 |
64 |
0.5 － 256 |
Levofloxacin (Levaquin, Quixin) |
109 |
| Pseudomonas aeruginosa |
4 |
16 |
0.5 － 16 |
Levofloxacin (Levaquin, Quixin) |
59 |
| Pseudomonas aeruginosa |
8 |
32 |
≤0.25 － >128 |
Levofloxacin (Levaquin, Quixin) |
371 |
| Pseudomonas aeruginosa |
32 |
64 |
32 － 128 |
Levofloxacin (Levaquin, Quixin) |
217 |
| Pseudomonas aeruginosa |
- |
4 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
341 |
| Pseudomonas aeruginosa |
- |
4 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
1044 |
| Pseudomonas aeruginosa |
>- |
>4 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
1358 |
| Pseudomonas aeruginosa |
- |
- |
0.25 － 32 |
Levofloxacin (Levaquin, Quixin) |
656 |
| Pseudomonas aeruginosa |
- |
- |
65 － ? |
Levofloxacin (Levaquin, Quixin) |
1132 |
| Pseudomonas aeruginosa (from respiratory tract infection + quinolone-susceptible) |
0.5 |
2 |
0.06 － 4 |
Levofloxacin (Levaquin, Quixin) |
268 |